Last reviewed · How we verify
Mucosta Tab.
At a glance
| Generic name | Mucosta Tab. |
|---|---|
| Also known as | Mucosta |
| Sponsor | Korea Otsuka Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.
- A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab. (PHASE4)
- A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis (PHASE3)
- A Study to Evaluate the Efficacy and Safety of AD-203 (PHASE3)
- A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis (PHASE4)
- Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia (PHASE4)
- Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy (PHASE4)
- A Drug Interaction Study of Mosapride and Rebamipide (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |